-
MERCK SHARP & DOHME CORP. v. ACTAVIS LABORATORIES FL, INC. et al DC CAFC
- 3:15-cv-06075
- D.N.J.
- Judge: Peter G. Sheridan
+1
- Filed: 08/06/2015
- Closed: 09/29/2017
- Latest Docket Entry: 05/03/2018
- PACER
- Docket updated daily
1
Plaintiff
4
Defendants
1
Accused
Product
1
Patent-in-Suit
786
Days in
Litigation
-
MERCK SHARP & DOHME CORP. v. ACTAVIS LABORATORIES FL, INC. et al DC CAFC
- 3:15-cv-06075
- D.N.J.
- Judge: Peter G. Sheridan
+1
- Filed: 08/06/2015
- Closed: 09/29/2017
- Latest Docket Entry: 05/03/2018
- PACER
- Docket updated daily
Cause of Action
Infringement
Assigned Judge
Outcome Summary
- Patent Information
-
Validity & Enforceability
| Claim # | Claim Text | Outcome |
|---|---|---|
| 11 |
A compound represented by the formula ##STR104## or a pharmaceutically acceptable salt thereof.
|
Valid (102)
Entry 225 Entry 223 |
| 12 |
A pharmaceutically composition for treating or preventing a fungal infection comprising an antifungally effective amount of the compound of claim 11 together with a pharmaceutically acceptable carrier therefor.
|
Valid (102 and 103)
Entry 225 Entry 223 Entry 199 |
-
Infringement
Actavis Laboratories FL Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 100 mg Posaconazole Delayed Release tabletsPosaconazole Delayed Release Tablets 100mg | US 5,661,151 A |
11, 12
|
Infringement
Entry 238Entry 225 |
Actavis Pharma Incorporated
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 100 mg Posaconazole Delayed Release tabletsPosaconazole Delayed Release Tablets 100mg | US 5,661,151 A |
11, 12
|
Infringement
Entry 238Entry 225 |
Andrx Corporation
- 1 Detail
| Accused Product | Patent # | Claim # | Outcome |
|---|---|---|---|
| 100 mg Posaconazole Delayed Release tabletsPosaconazole Delayed Release Tablets 100mg | US 5,661,151 A |
11, 12
|
Infringement
Entry 238Entry 225 |
